The committee will reconsider whether GSK's meningococcal B vaccine, BEXSERO, should be funded for broader infant and adolescent populations under the National Immunisation Program after the item was added late to the agenda for its March meeting. …
PBAC to reconsider broader vaccine funding after late addition to March agenda
February 13, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
PBAC to reconsider broader vaccine funding after late addition to March agenda
February 13, 2026 - - Latest News -
Ten years of process 'improvements' is almost the point, says Anne Ruston
February 13, 2026 - - Latest News -
Senate scrutiny of PBS rules after Canberra family highlights lack of biologic access
February 12, 2026 - - Latest News -
There is no negotiation, yet, so be careful not to give the impression of conceding anything
February 11, 2026 - - Latest News -
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia
February 11, 2026 - - Latest News -
Amplia expands U.S. footprint as AMPLICITY pancreatic cancer trial gains momentum
February 11, 2026 - - Australian Biotech -
Canine osteoarthritis study offers compelling translational evidence for PPS
February 11, 2026 - - Australian Biotech